NeuroStar TMS has a well-established safety profile developed over more than 15 years of clinical use. Understanding what to expect helps patients make informed decisions and set appropriate expectations before beginning treatment.
Unlike systemic medications, TMS side effects are primarily local — at the site of stimulation — and do not involve the metabolic, hormonal, or gastrointestinal systems. The most commonly reported side effects resolve on their own within the first week or two of treatment.
Scalp discomfort or mild headache — The tapping sensation of the magnetic coil can cause discomfort at the stimulation site during early sessions. This typically diminishes significantly by the end of the first week as the scalp adapts. OTC pain relievers (acetaminophen or ibuprofen) may be taken prior to sessions if needed.
The most serious potential adverse event associated with TMS is seizure, with an estimated incidence of approximately 0.1% across all patients — comparable to the seizure risk of many antidepressant medications. Patients with a personal or strong family history of seizure disorder are typically excluded from TMS treatment. A thorough clinical screening at your consultation identifies and addresses contraindications.
TMS is contraindicated for patients with certain metal implants in or near the head and skull (not including dental fillings), cochlear implants, or implanted medical devices near the stimulation site. Active seizure disorders are also a contraindication. A comprehensive screening is completed at your free consultation.
Free consultation. We review your medical history and address all contraindications before your first session.